CD274 and neoplasm: It is important to recognize that limitations within all studies include the possibility for residual confounding factors such as the diverse range of tumor types considered, the absence of records pertaining to hormonal and PD-L1 status based on sex, and variations in biomarker expression cut-offs, which may influence the heterogenous results.